Citation: Je. Siegel et al., MONITORING HEPARIN-THERAPY - APTT RESULTS FROM PARTIAL-DRAW VS FULL-DRAW TUBES, AJCP. American journal of clinical pathology, 110(2), 1998, pp. 184-187
Citation: Vk. Swami et K. Sazama, LACK OF ADVERSE EFFECT FROM DECREASING PLATELET CONCENTRATE POOL SIZETO 4 IN CARDIOTHORACIC SURGERY PATIENTS, Transfusion, 37(9), 1997, pp. 159-159
Citation: K. Sazama, WHO SHOULD RECEIVE IRRADIATED BLOOD PRODUCTS - WHAT GUIDELINES DO LABORATORIES USE, PARTICULARLY IN CONTROVERSIAL SITUATIONS, SUCH AS AUTOLOGOUS STEM-CELL TRANSPLANTS, ESPECIALLY FOR PATIENTS UNDERGOING CHEMOTHERAPY, Laboratory medicine, 27(11), 1996, pp. 725-725
Authors:
HOLLAND PV
AOKI SK
KURAMOTO IK
ANDERSON S
SCHOENING V
FERNANDO L
SAZAMA K
Citation: Pv. Holland et al., ADVANTAGE OF 2ND-GENERATION HEPATITIS-C ANTIBODY TESTING IN PREVENTING TRANSFUSION-TRANSMITTED HEPATITIS, Transfusion, 33(9), 1993, pp. 190000057-190000057
Authors:
AOKI SK
HOLLAND PV
FERNANDO LP
KURAMOTO IK
ANDERSON S
SAZAMA K
SCHOENING V
JOHNSON P
WILBER JC
FENNER L
ALTER HJ
Citation: Sk. Aoki et al., EVIDENCE OF HEPATITIS IN PATIENTS RECEIVING TRANSFUSIONS OF BLOOD COMPONENTS CONTAINING ANTIBODY TO HEPATITIS-C, Blood, 82(3), 1993, pp. 1000-1005